Hospital admissions due to adverse drug reactions;Unerwunschte internmedizinische arzneimittelwirkungen bei spitaleintritt

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 24, 1999, Pages 915-922

  Lepori, V ^a   Perren, A ^a   Marone, C ^a  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

ACE inhibiting drug; Acetylsalicylic acid; Adverse drug reaction; Diuretics; Elderly patient; Hospital admission; Patient information

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIRHEUMATIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; CORTICOSTEROID; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROLEPTIC AGENT; ANTITHROMBOCYTIC AGENT; DRUG;

ADVERSE DRUG REACTION; ARTICLE; DEHYDRATION; GASTROINTESTINAL DISEASE; HOSPITAL ADMISSION; HUMAN; HYPERKALEMIA; HYPOKALEMIA; PATIENT COMPLIANCE; PATIENT INFORMATION; ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDY; FEMALE; INCIDENCE; ITALY; MALE; MIDDLE AGED; PATIENT EDUCATION; PROSPECTIVE STUDY; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR AGENTS; CROSS-SECTIONAL STUDIES; DIURETICS; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT EDUCATION; PHARMACEUTICAL PREPARATIONS; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES;

EID: 0033584001     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Crétin-Maitetiaz V, Matza L, Mingat J, Guignier M, Sbai A, Calop J-Y. Etude de 247 cas d'accidents thérapeutiques médicamenteux. Elaboration d'un programme de prévention. J Pharm Clin 1990;9:193-212.
2. Bigby J, Dunn J, Goldman L, Adams JB, Jen P, Landefeld CS, et al. Assessing the preventability of emergency hospital admissions. Am J Med 1987;83:1031-6.
3. Davidsen F, Haghfet T, Gram F, Brosen K. Adverse drug reactions and drug non-compliance as primary causes off admission to a cardiology department. Eur J Clin Pharmacol 1988;34:83-6.
4. Lakshmanan M, Hershey C, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986;146: 1931-4.
5. Leape L, Brennan T, Laird N, Lawthers A, Localio A, Barmes B, et al. The nature of adverse events in hospitalized patients. N Engl J Med 1991;324:377-84.
6. Brennan T, Leape L, Laird N, Hebert L., Localio A, Lawthers A, et al. Incidence of adverse events and negligence in hospitalized patients. N Engl J Med 1991;324:370-6.
7. Leape L, Bates D, Cullen D, Cooper J, Demonaco H, Gallivan T, et al. Systems analysis of adverse drug events. JAMA 1995;274:35-43.
8. Bates D, Cullen D, Laird N, Petersen L, Small S, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995;274:29-34.
9. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospitalized patients. JAMA 1991;266:2847-51.
10. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost of illness model. Arch Intern Med 1995;155: 1949-56.
11. Lesar TS, Briceland L, Stein DS. Factors related to errors in medications prescribing. JAMA 1997;277:312-7.
12. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. JAMA 1997;277: 301-6.
13. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997;277:307-11.
14. Fattinger KE, Roos M, Vergères P, Holenstc. Kind B, Stocker DN, et al. Die «Stiftung für Arzneimit. heit SAS/CHDM». strukturierte Datenerfassung und e. ultate zu unerwünschten Arzneimittelwirkungen bei h lisierten, internistischen Patienten. Schweiz Ärztezeiti. 1998;79:2615-8.
15. Hoigné R, Maurer P, Wymann R, Fritschy D, Maibach R, Hess T, et al. Häufigkeit, Bedeutung und Epidemiologie von medikamentösen Nebenwirkungen. Ther Umschau 1987; 12:929-37.
16. Nicolet P-A, Kuhn M, Wieland TH, Reinhart WH. Unerwünschte Arzneimittelwirkungen (UAW) bei Patienten einer Medizinischen Klinik. Schweiz Med Wochenschr 1998;128 (Suppl 96):34 S.
17. World Health Organization. Collaborating Centers for International Drug Monitoring. Geneva, Switzerland: World Health Organization; 1984. WHO publication DEM / NC / 84. 153 (E).
18. Karch FE, Lasagna L. Adverse drug reactions. JAMA 1975;234:1236-41.
19. Ponge T, Cottin S, Fruneau P, Ponge A, Van Wassenhove L, Larousse C. Pathologie iatrogène. Enquête prospective, lien avec la consommation médicamenteuse. Therapie 1989;44: 63-6.
20. Camé B. H+ - Die Spitäler der Schweiz: pers. Mitteilung.
21. Avorn J. Putting adverse events into perspective. JAMA 1997;277:341-2.
22. Naschitz JE, Yeshurun D, Odeh M, Bassan H, Rosner I, Stermer E, et al. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease. Am J Gastroenterol 1990;85:408-11.
23. Leivonen M, Sipponen P, Kivilaakso E. Gastric changes in coronary-operated patients with low-dose aspirin. Scand J Gastroenterol 1992;27:912-6.
24. Bellary SV, Isaacs PE, Lee FI. Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage. Am J Gastroenterol 1991;86:961-4.